HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine

BACKGROUND: Development of an HIV vaccine might be essential to ending the HIV/AIDS pandemic. However, vaccines can result in the emergence and spread of vaccine-resistant strains. Indeed, analyses of breakthrough infections in the HIV phase 3 vaccine trial RV144 identified HIV genotypes with differ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vaccine
Autors principals: Herbeck, Joshua T., Peebles, Kathryn, Edlefsen, Paul T., Rolland, Morgane, Murphy, James T., Gottlieb, Geoffrey S., Abernethy, Neil, Mullins, James I., Mittler, John E., Goodreau, Steven M.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6701864/
https://ncbi.nlm.nih.gov/pubmed/29241646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.12.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars